{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T04:02:44Z","timestamp":1793678564948,"version":"4.5.1"},"reference-count":180,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience & Biobehavioral Reviews"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.neubiorev.2016.01.001","type":"journal-article","created":{"date-parts":[[2016,1,16]],"date-time":"2016-01-16T12:41:57Z","timestamp":1452948117000},"page":"207-222","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":89,"special_numbering":"C","title":["The therapeutic potential of insulin-like growth factor-1 in central nervous system disorders"],"prefix":"10.1016","volume":"63","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5695-7122","authenticated-orcid":false,"given":"Jesse","family":"Costales","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Kolevzon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.neubiorev.2016.01.001_bib0005","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/BF01277964","article-title":"Insulin-like growth factor-1 receptors in human spinal cord: changes in amyotrophic lateral sclerosis","volume":"97","author":"Adem","year":"1994","journal-title":"J. Neural Transm. Gen. Sect."},{"issue":"10","key":"10.1016\/j.neubiorev.2016.01.001_bib0010","doi-asserted-by":"crossref","first-page":"4522","DOI":"10.1210\/en.2004-0488","article-title":"Cross-talk between phosphatidylinositol 3-kinase\/AKT and c-jun NH2-terminal kinase mediates survival of isolated human islets","volume":"145","author":"Aikin","year":"2004","journal-title":"Endocrinology"},{"issue":"2","key":"10.1016\/j.neubiorev.2016.01.001_bib0015","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1210\/jcem.84.2.5455","article-title":"Insulin-like growth factor-I and cognitive function in healthy older men","volume":"84","author":"Aleman","year":"1999","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"10.1016\/j.neubiorev.2016.01.001_bib0020","first-page":"485","article-title":"The aberrant behavior checklist: a behavior rating scale for the assessment of treatment effects","volume":"89","author":"Aman","year":"1985","journal-title":"Am. J. Ment. Defic."},{"key":"10.1016\/j.neubiorev.2016.01.001_bib0025","doi-asserted-by":"crossref","unstructured":"American Psychiatric Association, A. P. A. D. S. M. T. F. (2013). Diagnostic and statistical manual of mental disorders: DSM-5. from http:\/\/dsm.psychiatryonline.org\/book.aspx?bookid=556.","DOI":"10.1176\/appi.books.9780890425596"},{"issue":"2","key":"10.1016\/j.neubiorev.2016.01.001_bib0030","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/13810","article-title":"Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2","volume":"23","author":"Amir","year":"1999","journal-title":"Nat. Genet."},{"issue":"2","key":"10.1016\/j.neubiorev.2016.01.001_bib0035","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1748-1716.1988.tb08314.x","article-title":"Differing expression of insulin-like growth factor I in the developing and in the adult rat cerebellum","volume":"132","author":"Andersson","year":"1988","journal-title":"Acta Physiol. Scand."},{"issue":"6","key":"10.1016\/j.neubiorev.2016.01.001_bib0040","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1523\/JNEUROSCI.18-06-02118.1998","article-title":"Insulin-like growth factor-I is a differentiation factor for postmitotic CNS stem cell-derived neuronal precursors: distinct actions from those of brain-derived neurotrophic factor","volume":"18","author":"Arsenijevic","year":"1998","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.neubiorev.2016.01.001_bib0045","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1242\/dev.111.1.105","article-title":"Expression of IGF-1 and -II mRNA in the brain and craniofacial region of the rat fetus","volume":"111","author":"Ayer-le","year":"1991","journal-title":"Development"},{"issue":"1","key":"10.1016\/j.neubiorev.2016.01.001_bib0050","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0169-328X(91)90054-2","article-title":"Insulin-like growth factor I mRNA levels are developmentally regulated in specific regions of the rat brain","volume":"10","author":"Bach","year":"1991","journal-title":"Brain Res. Mol. Brain Res."},{"issue":"2","key":"10.1016\/j.neubiorev.2016.01.001_bib0055","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.npep.2004.11.001","article-title":"Central penetration and stability of N-terminal tripeptide of insulin-like growth factor-I, glycine-proline-glutamate in adult rat","volume":"39","author":"Baker","year":"2005","journal-title":"Neuropeptides"},{"issue":"1","key":"10.1016\/j.neubiorev.2016.01.001_bib0060","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0092-8674(05)80085-6","article-title":"Role of insulin-like growth factors in embryonic and postnatal growth","volume":"75","author":"Baker","year":"1993","journal-title":"Cell"},{"issue":"9770","key":"10.1016\/j.neubiorev.2016.01.001_bib0065","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/S0140-6736(10)61349-9","article-title":"Alzheimer\u2019s disease","volume":"377","author":"Ballard","year":"2011","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.neubiorev.2016.01.001_bib0070","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1677\/joe.0.1280197","article-title":"Plasma clearance and tissue distribution of labelled insulin-like growth factor-I (IGF-I), IGF-II and des(1\u20133)IGF-I in rats","volume":"128","author":"Ballard","year":"1991","journal-title":"J. Endocrinol."},{"issue":"12","key":"10.1016\/j.neubiorev.2016.01.001_bib0075","doi-asserted-by":"crossref","first-page":"3633","DOI":"10.1002\/j.1460-2075.1987.tb02695.x","article-title":"Insulin-like growth factor I in cultured rat astrocytes: expression of the gene, and receptor tyrosine kinase","volume":"6","author":"Ballotti","year":"1987","journal-title":"EMBO J."},{"issue":"1","key":"10.1016\/j.neubiorev.2016.01.001_bib0080","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1177\/1073858409339215","article-title":"Astrocytes and synaptic plasticity","volume":"16","author":"Barker","year":"2010","journal-title":"Neuroscientist"},{"issue":"2","key":"10.1016\/j.neubiorev.2016.01.001_bib0085","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.ab.2003.08.032","article-title":"Pharmacokinetics of glycine-proline-glutamate, the N-terminal tripeptide of insulin-like growth factor-1, in rats","volume":"323","author":"Batchelor","year":"2003","journal-title":"Anal. Biochem."},{"issue":"20","key":"10.1016\/j.neubiorev.2016.01.001_bib0090","doi-asserted-by":"crossref","first-page":"11843","DOI":"10.1016\/S0021-9258(18)80143-0","article-title":"High molecular weight insulin-like growth factor binding protein complex. Purification and properties of the acid-labile subunit from human serum","volume":"264","author":"Baxter","year":"1989","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.neubiorev.2016.01.001_bib0095","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/0896-6273(95)90216-3","article-title":"Igf1 gene disruption results in reduced brain size, CNS hypomyelination, and loss of hippocampal granule and striatal parvalbumin-containing neurons","volume":"14","author":"Beck","year":"1995","journal-title":"Neuron"},{"key":"10.1016\/j.neubiorev.2016.01.001_bib0100","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.brainres.2010.11.078","article-title":"Etiological heterogeneity in autism spectrum disorders: more than 100 genetic and genomic disorders and still counting","volume":"1380","author":"Betancur","year":"2011","journal-title":"Brain Res."},{"key":"10.1016\/j.neubiorev.2016.01.001_bib0105","doi-asserted-by":"crossref","unstructured":"Bodfish, J.W., Symons, F., Lewis, M.H., 1999. The Repetitive Behavior Scales (RBS). Western Carolina Center Research Reports.","DOI":"10.1037\/t17338-000"},{"issue":"2","key":"10.1016\/j.neubiorev.2016.01.001_bib0110","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s00441-006-0274-5","article-title":"The postsynaptic density","volume":"326","author":"Boeckers","year":"2006","journal-title":"Cell Tissue Res."},{"issue":"1","key":"10.1016\/j.neubiorev.2016.01.001_bib0115","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1006\/bbrc.1999.1489","article-title":"Proline-rich synapse-associated proteins ProSAP1 and ProSAP2 interact with synaptic proteins of the SAPAP\/GKAP family","volume":"264","author":"Boeckers","year":"1999","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.neubiorev.2016.01.001_bib0120","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1677\/joe.0.1700063","article-title":"The acid-labile subunit (ALS) of the 150kDa IGF-binding protein complex: an important but forgotten component of the circulating IGF system","volume":"170","author":"Boisclair","year":"2001","journal-title":"J. Endocrinol."},{"issue":"11","key":"10.1016\/j.neubiorev.2016.01.001_bib0125","doi-asserted-by":"crossref","first-page":"3442","DOI":"10.1523\/JNEUROSCI.11-11-03442.1991","article-title":"Transient IGF-I gene expression during the maturation of functionally related central projection neurons","volume":"11","author":"Bondy","year":"1991","journal-title":"J. Neurosci."},{"issue":"5443","key":"10.1016\/j.neubiorev.2016.01.001_bib0130","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1126\/science.286.5443.1358","article-title":"Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and -independent mechanisms","volume":"286","author":"Bonni","year":"1999","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.neubiorev.2016.01.001_bib0135","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1212\/WNL.51.2.583","article-title":"A placebo-controlled trial of insulin-like growth factor-I in amyotrophic lateral sclerosis. European ALS\/IGF-I Study Group","volume":"51","author":"Borasio","year":"1998","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.neubiorev.2016.01.001_bib0140","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/2040-2392-1-15","article-title":"Haploinsufficiency of the autism-associated Shank3 gene leads to deficits in synaptic function, social interaction, and social communication","volume":"1","author":"Bozdagi","year":"2010","journal-title":"Mol. Autism"},{"issue":"1","key":"10.1016\/j.neubiorev.2016.01.001_bib0145","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/2040-2392-4-9","article-title":"Insulin-like growth factor-1 rescues synaptic and motor deficits in a mouse model of autism and developmental delay","volume":"4","author":"Bozdagi","year":"2013","journal-title":"Mol. Autism"},{"issue":"10","key":"10.1016\/j.neubiorev.2016.01.001_bib0150","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1093\/cercor\/10.10.1045","article-title":"FMRP involvement in formation of synapses among cultured hippocampal neurons","volume":"10","author":"Braun","year":"2000","journal-title":"Cereb. Cortex"},{"issue":"2","key":"10.1016\/j.neubiorev.2016.01.001_bib0155","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/med.20012","article-title":"Brain and cancer: the protective role of erythropoietin","volume":"25","author":"Buemi","year":"2005","journal-title":"Med. Res. Rev."},{"issue":"3","key":"10.1016\/j.neubiorev.2016.01.001_bib0160","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/S0002-9440(10)64606-8","article-title":"Insulin-like growth factor-1 fails to enhance central nervous system myelin repair during autoimmune demyelination","volume":"157","author":"Cannella","year":"2000","journal-title":"Am. J. Pathol."},{"issue":"6","key":"10.1016\/j.neubiorev.2016.01.001_bib0165","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1097\/01.WCB.0000067720.12805.6F","article-title":"Insulin-like growth factor (IGF)-1 suppresses oligodendrocyte caspase-3 activation and increases glial proliferation after ischemia in near-term fetal sheep","volume":"23","author":"Cao","year":"2003","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.neubiorev.2016.01.001_bib0170","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1749-6632.1993.tb26219.x","article-title":"Activity-sensitive signaling by muscle-derived insulin-like growth factors in the developing and regenerating neuromuscular system","volume":"692","author":"Caroni","year":"1993","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"4","key":"10.1016\/j.neubiorev.2016.01.001_bib0175","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1083\/jcb.110.4.1307","article-title":"Nerve sprouting in innervated adult skeletal muscle induced by exposure to elevated levels of insulin-like growth factors","volume":"110","author":"Caroni","year":"1990","journal-title":"J. Cell. Biol."},{"issue":"12","key":"10.1016\/j.neubiorev.2016.01.001_bib0180","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1038\/nm1202-793","article-title":"Serum insulin-like growth factor I regulates brain amyloid-beta levels","volume":"8","author":"Carro","year":"2002","journal-title":"Nat. Med."},{"issue":"4","key":"10.1016\/j.neubiorev.2016.01.001_bib0185","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/0896-6273(93)90173-O","article-title":"Insulin-like growth factor I increases brain growth and central nervous system myelination in transgenic mice","volume":"10","author":"Carson","year":"1993","journal-title":"Neuron"},{"issue":"27","key":"10.1016\/j.neubiorev.2016.01.001_bib0190","doi-asserted-by":"crossref","first-page":"9941","DOI":"10.1073\/pnas.1311685111","article-title":"Functional recovery with recombinant human IGF1 treatment in a mouse model of Rett Syndrome","volume":"111","author":"Castro","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.neubiorev.2016.01.001_bib0195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jnr.10634","article-title":"Insulin-like growth factor 1 is essential for normal dendritic growth","volume":"73","author":"Cheng","year":"2003","journal-title":"J. Neurosci. Res."},{"issue":"3","key":"10.1016\/j.neubiorev.2016.01.001_bib0200","first-page":"548","article-title":"Neurochemical and behavioral effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in rat, guinea pig, and monkey","volume":"20","author":"Chiueh","year":"1984","journal-title":"Psychopharmacol. Bull."},{"issue":"2","key":"10.1016\/j.neubiorev.2016.01.001_bib0205","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.cellsig.2005.04.005","article-title":"Peptide growth factors signal differentially through protein kinase C to extracellular signal-regulated kinases in neonatal cardiomyocytes","volume":"18","author":"Clerk","year":"2006","journal-title":"Cell. Signal."},{"issue":"21","key":"10.1016\/j.neubiorev.2016.01.001_bib0210","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1093\/hmg\/ddh282","article-title":"Mild overexpression of MeCP2 causes a progressive neurological disorder in mice","volume":"13","author":"Collins","year":"2004","journal-title":"Hum. Mol. Genet."},{"issue":"10","key":"10.1016\/j.neubiorev.2016.01.001_bib0215","doi-asserted-by":"crossref","first-page":"5401","DOI":"10.1073\/pnas.94.10.5401","article-title":"Abnormal dendritic spines in fragile X knockout mice: maturation and pruning deficits","volume":"94","author":"Comery","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"4","key":"10.1016\/j.neubiorev.2016.01.001_bib0220","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1111\/j.1476-5381.2011.01302.x","article-title":"Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS)","volume":"164","author":"Constantinescu","year":"2011","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.neubiorev.2016.01.001_bib0225","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.neulet.2012.05.029","article-title":"Insulin-like growth factor 1 (IGF1) and its active peptide (1\u20133)IGF1 enhance the expression of synaptic markers in neuronal circuits through different cellular mechanisms","volume":"520","author":"Corvin","year":"2012","journal-title":"Neurosci. Lett."},{"issue":"35","key":"10.1016\/j.neubiorev.2016.01.001_bib0230","doi-asserted-by":"crossref","first-page":"12560","DOI":"10.1073\/pnas.0506071102","article-title":"Reduced cortical activity due to a shift in the balance between excitation and inhibition in a mouse model of Rett syndrome","volume":"102","author":"Dani","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.neubiorev.2016.01.001_bib0235","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.cell.2011.06.013","article-title":"FMRP stalls ribosomal translocation on mRNAs linked to synaptic function and autism","volume":"146","author":"Darnell","year":"2011","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.neubiorev.2016.01.001_bib0240","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0092-8674(00)80405-5","article-title":"Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery","volume":"91","author":"Datta","year":"1997","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.neubiorev.2016.01.001_bib0245","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1002\/mrd.1080350418","article-title":"IGF-I and the IGF-I receptor in development of nonmammalian vertebrates","volume":"35","author":"de Pablo","year":"1993","journal-title":"Mol. Reprod. Dev."},{"issue":"1","key":"10.1016\/j.neubiorev.2016.01.001_bib0250","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s12017-015-8341-2","article-title":"NNZ-2566, a novel analog of (1\u20133) IGF-1, as a potential therapeutic agent for fragile X syndrome","volume":"17","author":"Deacon","year":"2015","journal-title":"Neuromol. Med."},{"issue":"2","key":"10.1016\/j.neubiorev.2016.01.001_bib0255","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1006\/exnr.2002.7891","article-title":"Modeling Parkinson\u2019s disease in rats: an evaluation of 6-OHDA lesions of the nigrostriatal pathway","volume":"175","author":"Deumens","year":"2002","journal-title":"Exp. Neurol."},{"issue":"2","key":"10.1016\/j.neubiorev.2016.01.001_bib0260","first-page":"1","article-title":"Prevalence of autism spectrum disorder among children aged 8 years\u2014autism and developmental disabilities monitoring network, 11 sites, United States, 2010","volume":"63","author":"Developmental Disabilities Monitoring Network Surveillance Year Principal Investigators","year":"2014","journal-title":"MMWR Surveill. Summ."},{"issue":"22","key":"10.1016\/j.neubiorev.2016.01.001_bib0265","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.1038\/sj.onc.1210421","article-title":"MAP kinase signalling pathways in cancer","volume":"26","author":"Dhillon","year":"2007","journal-title":"Oncogene"},{"issue":"26","key":"10.1016\/j.neubiorev.2016.01.001_bib0270","doi-asserted-by":"crossref","first-page":"9855","DOI":"10.1073\/pnas.0403172101","article-title":"Acute neuroprotective synergy of erythropoietin and insulin-like growth factor I","volume":"101","author":"Digicaylioglu","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"8","key":"10.1016\/j.neubiorev.2016.01.001_bib0275","doi-asserted-by":"crossref","first-page":"2900","DOI":"10.1172\/JCI41069","article-title":"Divergent roles of growth factors in the GnRH regulation of puberty in mice","volume":"120","author":"Divall","year":"2010","journal-title":"J. Clin. Invest."},{"issue":"1\u20132","key":"10.1016\/j.neubiorev.2016.01.001_bib0280","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/0169-328X(96)00081-2","article-title":"Distribution and levels of insulin-like growth factor (IGF-I and IGF-II) and insulin receptor binding sites in the spinal cords of amyotrophic lateral sclerosis (ALS) patients","volume":"41","author":"Dore","year":"1996","journal-title":"Brain Res. Mol. Brain Res."},{"issue":"6","key":"10.1016\/j.neubiorev.2016.01.001_bib0285","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.4049\/jimmunol.164.6.3207","article-title":"TGF-beta 2 reduces demyelination, virus antigen expression, and macrophage recruitment in a viral model of multiple sclerosis","volume":"164","author":"Drescher","year":"2000","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.neubiorev.2016.01.001_bib0290","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1136\/jnnp.31.6.535","article-title":"An hereditary motor neurone disease with progressive denervation of muscle in the mouse: the mutant \u2018wobbler\u2019","volume":"31","author":"Duchen","year":"1968","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"1","key":"10.1016\/j.neubiorev.2016.01.001_bib0295","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/ng1933","article-title":"Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders","volume":"39","author":"Durand","year":"2007","journal-title":"Nat. Genet."},{"issue":"12","key":"10.1016\/j.neubiorev.2016.01.001_bib0300","doi-asserted-by":"crossref","first-page":"4673","DOI":"10.1210\/jc.2012-2063","article-title":"Insulin-like growth factor-I and insulin-like growth factor binding protein-3 in Alzheimer\u2019s disease","volume":"97","author":"Duron","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2\u20133","key":"10.1016\/j.neubiorev.2016.01.001_bib0305","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0378-4274(02)00428-9","article-title":"Apoptotic mechanisms and antiapoptotic therapy in the MPTP model of Parkinson\u2019s disease","volume":"139","author":"Eberhardt","year":"2003","journal-title":"Toxicol. Lett."},{"issue":"1","key":"10.1016\/j.neubiorev.2016.01.001_bib0310","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.expneurol.2007.09.022","article-title":"Human neural progenitor cells over-expressing IGF-1 protect dopamine neurons and restore function in a rat model of Parkinson\u2019s disease","volume":"209","author":"Ebert","year":"2008","journal-title":"Exp. Neurol."},{"issue":"10","key":"10.1016\/j.neubiorev.2016.01.001_bib0315","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1007\/s00424-013-1287-z","article-title":"PI3K-dependent actions of insulin and IGF-I on seminiferous tubules from immature rats","volume":"465","author":"Escott","year":"2013","journal-title":"Pflugers Arch."},{"issue":"4","key":"10.1016\/j.neubiorev.2016.01.001_bib0320","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/nrn3209","article-title":"The many faces of insulin-like peptide signalling in the brain","volume":"13","author":"Fernandez","year":"2012","journal-title":"Nat. Rev. Neurosci."},{"issue":"18","key":"10.1016\/j.neubiorev.2016.01.001_bib0325","doi-asserted-by":"crossref","first-page":"3151","DOI":"10.1038\/sj.onc.1207542","article-title":"Target of rapamycin (TOR): an integrator of nutrient and growth factor signals and coordinator of cell growth and cell cycle progression","volume":"23","author":"Fingar","year":"2004","journal-title":"Oncogene"},{"issue":"6","key":"10.1016\/j.neubiorev.2016.01.001_bib0330","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1210\/er.2001-0033","article-title":"Cellular actions of the insulin-like growth factor binding proteins","volume":"23","author":"Firth","year":"2002","journal-title":"Endocr. Rev."},{"issue":"5","key":"10.1016\/j.neubiorev.2016.01.001_bib0335","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1210\/endo.143.5.8764","article-title":"Impaired blockade of insulin-like growth factor I (IGF-I)-induced hypoglycemia by IGF binding protein-3 analog with reduced ternary complex-forming ability","volume":"143","author":"Firth","year":"2002","journal-title":"Endocrinology"},{"issue":"3","key":"10.1016\/j.neubiorev.2016.01.001_bib0340","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1002\/jcp.10417","article-title":"Simultaneous activation of several second messengers in hypoxia-induced hyperpermeability of brain derived endothelial cells","volume":"198","author":"Fischer","year":"2004","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.neubiorev.2016.01.001_bib0345","doi-asserted-by":"crossref","first-page":"164","DOI":"10.3171\/2009.2.JNS081199","article-title":"Intranasal delivery of erythropoietin plus insulin-like growth factor-I for acute neuroprotection in stroke. Laboratory investigation","author":"Fletcher","year":"2009","journal-title":"J. Neurosurg."},{"issue":"1","key":"10.1016\/j.neubiorev.2016.01.001_bib0350","first-page":"23","article-title":"Fmr1 knockout mice: a model to study fragile X mental retardation. The Dutch-Belgian Fragile X Consortium","volume":"78","author":"Anon","year":"1994","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.neubiorev.2016.01.001_bib0355","doi-asserted-by":"crossref","first-page":"654","DOI":"10.2337\/diab.35.6.654","article-title":"Binding and internalization of insulin and insulin-like growth factors by isolated brain microvessels","volume":"35","author":"Frank","year":"1986","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.neubiorev.2016.01.001_bib0360","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1191\/1352458502ms768oa","article-title":"A pilot study of recombinant insulin-like growth factor-1 in seven multiple sderosis patients","volume":"8","author":"Frank","year":"2002","journal-title":"Mult. Scler."},{"issue":"10","key":"10.1016\/j.neubiorev.2016.01.001_bib0365","doi-asserted-by":"crossref","first-page":"3315","DOI":"10.1096\/fj.09-132043","article-title":"Neuronal IGF-1 resistance reduces Abeta accumulation and protects against premature death in a model of Alzheimer\u2019s disease","volume":"23","author":"Freude","year":"2009","journal-title":"FASEB J."},{"issue":"15","key":"10.1016\/j.neubiorev.2016.01.001_bib0370","doi-asserted-by":"crossref","first-page":"13325","DOI":"10.1074\/jbc.M211398200","article-title":"Type 1 insulin-like growth factor receptor (IGF-IR) signaling inhibits apoptosis signal-regulating kinase 1 (ASK1)","volume":"278","author":"Galvan","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.neubiorev.2016.01.001_bib0375","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/ajmg.a.30709","article-title":"Sequence of abnormal dendritic spine development in primary somatosensory cortex of a mouse model of the fragile X mental retardation syndrome","volume":"135","author":"Galvez","year":"2005","journal-title":"Am. J. Med. Genet. A"},{"issue":"4","key":"10.1016\/j.neubiorev.2016.01.001_bib0380","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1001\/archpedi.161.4.343","article-title":"The lifetime distribution of the incremental societal costs of autism","volume":"161","author":"Ganz","year":"2007","journal-title":"Arch. Pediatr. Adolesc. Med."},{"issue":"6","key":"10.1016\/j.neubiorev.2016.01.001_bib0385","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/ejhg.2008.61","article-title":"Fragile X syndrome","volume":"16","author":"Garber","year":"2008","journal-title":"Eur. J. Hum. Genet."},{"issue":"3","key":"10.1016\/j.neubiorev.2016.01.001_bib0390","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.cell.2008.10.016","article-title":"Autism: many genes, common pathways?","volume":"135","author":"Geschwind","year":"2008","journal-title":"Cell"},{"issue":"Suppl. 1","key":"10.1016\/j.neubiorev.2016.01.001_bib0395","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1038\/sj.cdd.4401450","article-title":"Erythropoietin as an antiapoptotic, tissue-protective cytokine","volume":"11","author":"Ghezzi","year":"2004","journal-title":"Cell Death Differ."},{"issue":"3","key":"10.1016\/j.neubiorev.2016.01.001_bib0400","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0306-4522(98)00338-8","article-title":"The effects of the N-terminal tripeptide of insulin-like growth factor-1, glycine-proline-glutamate in different regions following hypoxic-ischemic brain injury in adult rats","volume":"89","author":"Guan","year":"1999","journal-title":"Neuroscience"},{"issue":"12","key":"10.1016\/j.neubiorev.2016.01.001_bib0405","doi-asserted-by":"crossref","first-page":"5484","DOI":"10.1210\/endo.137.12.8940375","article-title":"In vivo effects of insulin-like growth factor-I on the development of sensory pathways: analysis of the primary somatic sensory cortex (S1) of transgenic mice","volume":"137","author":"Gutierrez-Ospina","year":"1996","journal-title":"Endocrinology"},{"key":"10.1016\/j.neubiorev.2016.01.001_bib0410","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0920-9964(03)00224-X","article-title":"Hypothesis: do insulin-like growth factors underlie associations of birth complications, fetal and pre-adult growth with schizophrenia?","volume":"71","author":"Gunnell","year":"2004","journal-title":"Schizophr. Res."},{"issue":"2","key":"10.1016\/j.neubiorev.2016.01.001_bib0415","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/mrdd.10020","article-title":"Clinical manifestations and stages of Rett syndrome","volume":"8","author":"Hagberg","year":"2002","journal-title":"Ment. Retard. Dev. Disabil. Res. Rev."},{"issue":"Suppl","key":"10.1016\/j.neubiorev.2016.01.001_bib0420","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/0022-510X(95)00081-C","article-title":"Beneficial effects of insulin-like growth factor-I on wobbler mouse motoneuron disease","volume":"129","author":"Hantai","year":"1995","journal-title":"J. Neurol. Sci."},{"issue":"17","key":"10.1016\/j.neubiorev.2016.01.001_bib0425","doi-asserted-by":"crossref","first-page":"9666","DOI":"10.1073\/pnas.171301998","article-title":"p70S6 kinase signals cell survival as well as growth, inactivating the pro-apoptotic molecule BAD","volume":"98","author":"Harada","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.neubiorev.2016.01.001_bib0430","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0014-4886(74)90015-6","article-title":"A comparative study of denervation in muscles from mice with inherited progressive neuromuscular disorders","volume":"42","author":"Harris","year":"1974","journal-title":"Exp. Neurol."},{"issue":"44","key":"10.1016\/j.neubiorev.2016.01.001_bib0435","doi-asserted-by":"crossref","first-page":"27936","DOI":"10.1074\/jbc.272.44.27936","article-title":"Binding sites and binding properties of binary and ternary complexes of insulin-like growth factor-II (IGF-II), IGF-binding protein-3, and acid-labile subunit","volume":"272","author":"Hashimoto","year":"1997","journal-title":"J. Biol. Chem."},{"issue":"16","key":"10.1016\/j.neubiorev.2016.01.001_bib0440","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1101\/gad.1212704","article-title":"Upstream and downstream of mTOR","volume":"18","author":"Hay","year":"2004","journal-title":"Genes Dev."},{"issue":"1381","key":"10.1016\/j.neubiorev.2016.01.001_bib0445","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1098\/rstb.1999.0378","article-title":"Synapsins as regulators of neurotransmitter release","volume":"354","author":"Hilfiker","year":"1999","journal-title":"Philos. Trans. R. Soc. Lond. B: Biol. Sci."},{"issue":"45","key":"10.1016\/j.neubiorev.2016.01.001_bib0450","doi-asserted-by":"crossref","first-page":"10201","DOI":"10.1523\/JNEUROSCI.3246-04.2004","article-title":"Insulin-like growth factor-I accelerates the cell cycle by decreasing G1 phase length and increases cell cycle reentry in the embryonic cerebral cortex","volume":"24","author":"Hodge","year":"2004","journal-title":"J. Neurosci."},{"issue":"3","key":"10.1016\/j.neubiorev.2016.01.001_bib0455","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/j.1601-183X.2012.00768.x","article-title":"Altered mTOR signaling and enhanced CYFIP2 expression levels in subjects with fragile X syndrome","volume":"11","author":"Hoeffer","year":"2012","journal-title":"Genes Brain Behav."},{"issue":"7","key":"10.1016\/j.neubiorev.2016.01.001_bib0460","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1210\/endo.141.7.7550","article-title":"A targeted partial invalidation of the insulin-like growth factor I receptor gene in mice causes a postnatal growth deficit","volume":"141","author":"Holzenberger","year":"2000","journal-title":"Endocrinology"},{"issue":"11","key":"10.1016\/j.neubiorev.2016.01.001_bib0465","doi-asserted-by":"crossref","first-page":"7746","DOI":"10.1073\/pnas.122205699","article-title":"Altered synaptic plasticity in a mouse model of fragile X mental retardation","volume":"99","author":"Huber","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"15","key":"10.1016\/j.neubiorev.2016.01.001_bib0470","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1101\/gad.1110003","article-title":"Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling","volume":"17","author":"Inoki","year":"2003","journal-title":"Genes Dev."},{"issue":"10","key":"10.1016\/j.neubiorev.2016.01.001_bib0475","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1093\/cercor\/10.10.1038","article-title":"Dendritic spine structural anomalies in fragile-X mental retardation syndrome","volume":"10","author":"Irwin","year":"2000","journal-title":"Cereb. Cortex"},{"issue":"Suppl. 1","key":"10.1016\/j.neubiorev.2016.01.001_bib0480","doi-asserted-by":"crossref","first-page":"S206","DOI":"10.1016\/S0387-7604(01)00351-5","article-title":"Neurobiology of Rett syndrome: a genetic disorder of synapse development","volume":"23","author":"Johnston","year":"2001","journal-title":"Brain Dev."},{"issue":"1","key":"10.1016\/j.neubiorev.2016.01.001_bib0485","first-page":"3","article-title":"Insulin-like growth factors and their binding proteins: biological actions","volume":"16","author":"Jones","year":"1995","journal-title":"Endocr. Rev."},{"issue":"2","key":"10.1016\/j.neubiorev.2016.01.001_bib0490","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.neuron.2006.09.032","article-title":"Synaptic memories upside down: bidirectional plasticity at cerebellar parallel fiber-Purkinje cell synapses","volume":"52","author":"Jorntell","year":"2006","journal-title":"Neuron"},{"issue":"3","key":"10.1016\/j.neubiorev.2016.01.001_bib0495","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1002\/ana.22070","article-title":"Erythropoietin plus insulin-like growth factor-I protects against neuronal damage in a murine model of human immunodeficiency virus-associated neurocognitive disorders","volume":"68","author":"Kang","year":"2010","journal-title":"Ann. Neurol."},{"issue":"2","key":"10.1016\/j.neubiorev.2016.01.001_bib0500","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1152\/physrev.00011.2010","article-title":"Physiology of microglia","volume":"91","author":"Kettenmann","year":"2011","journal-title":"Physiol. Rev."},{"issue":"12","key":"10.1016\/j.neubiorev.2016.01.001_bib0505","doi-asserted-by":"crossref","first-page":"4596","DOI":"10.1073\/pnas.1311141111","article-title":"Safety, pharmacokinetics, and preliminary assessment of efficacy of mecasermin (recombinant human IGF-1) for the treatment of Rett syndrome","volume":"111","author":"Khwaja","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"9769","key":"10.1016\/j.neubiorev.2016.01.001_bib0510","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/S0140-6736(10)61156-7","article-title":"Amyotrophic lateral sclerosis","volume":"377","author":"Kiernan","year":"2011","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.neubiorev.2016.01.001_bib0515","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/nrn1517","article-title":"PDZ domain proteins of synapses","volume":"5","author":"Kim","year":"2004","journal-title":"Nat. Rev. Neurosci."},{"issue":"1","key":"10.1016\/j.neubiorev.2016.01.001_bib0520","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/2040-2392-5-54","article-title":"A pilot controlled trial of insulin-like growth factor-1 in children with Phelan-McDermid syndrome","volume":"5","author":"Kolevzon","year":"2014","journal-title":"Mol. Autism"},{"issue":"4","key":"10.1016\/j.neubiorev.2016.01.001_bib0525","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.cytogfr.2006.02.002","article-title":"Regulation of apoptosis by insulin-like growth factor (IGF)-I","volume":"17","author":"Kooijman","year":"2006","journal-title":"Cytokine Growth Factor Rev."},{"issue":"10","key":"10.1016\/j.neubiorev.2016.01.001_bib0530","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1002\/j.1460-2075.1994.tb06515.x","article-title":"Involvement of phosphoinositide 3-kinase in insulin- or IGF-1-induced membrane ruffling","volume":"13","author":"Kotani","year":"1994","journal-title":"EMBO J."},{"issue":"49","key":"10.1016\/j.neubiorev.2016.01.001_bib0535","doi-asserted-by":"crossref","first-page":"11288","DOI":"10.1523\/JNEUROSCI.2284-05.2005","article-title":"Regulation of dendritic morphogenesis by Ras-PI3K-Akt-mTOR and Ras-MAPK signaling pathways","volume":"25","author":"Kumar","year":"2005","journal-title":"J. Neurosci."},{"issue":"6","key":"10.1016\/j.neubiorev.2016.01.001_bib0540","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1212\/WNL.49.6.1621","article-title":"Effect of recombinant human insulin-like growth factor-I on progression of ALS. A placebo-controlled study. The North America ALS\/IGF-I Study Group","volume":"49","author":"Lai","year":"1997","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.neubiorev.2016.01.001_bib0545","doi-asserted-by":"crossref","first-page":"e1004580","DOI":"10.1371\/journal.pgen.1004580","article-title":"Meta-analysis of SHANK mutations in autism spectrum disorders: a gradient of severity in cognitive impairments","volume":"10","author":"Leblond","year":"2014","journal-title":"PLoS Genet."},{"issue":"1","key":"10.1016\/j.neubiorev.2016.01.001_bib0550","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/0306-4522(93)90303-W","article-title":"Localization of insulin-like growth factor binding protein-2 messenger RNA during postnatal brain development: correlation with insulin-like growth factors I and II","volume":"53","author":"Lee","year":"1993","journal-title":"Neuroscience"},{"issue":"1","key":"10.1016\/j.neubiorev.2016.01.001_bib0555","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1006\/exnr.1993.1177","article-title":"Insulin-like growth factor-I: potential for treatment of motor neuronal disorders","volume":"124","author":"Lewis","year":"1993","journal-title":"Exp. Neurol."},{"issue":"5","key":"10.1016\/j.neubiorev.2016.01.001_bib0560","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1097\/00005072-199805000-00006","article-title":"Chronic relapsing experimental autoimmune encephalomyelitis: effects of insulin-like growth factor-I treatment on clinical deficits, lesion severity, glial responses, and blood brain barrier defects","volume":"57","author":"Li","year":"1998","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"1","key":"10.1016\/j.neubiorev.2016.01.001_bib0565","first-page":"59","article-title":"Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r)","volume":"75","author":"Liu","year":"1993","journal-title":"Cell"},{"issue":"16","key":"10.1016\/j.neubiorev.2016.01.001_bib0570","doi-asserted-by":"crossref","first-page":"6033","DOI":"10.1073\/pnas.0401626101","article-title":"Expression of MeCP2 in postmitotic neurons rescues Rett syndrome in mice","volume":"101","author":"Luikenhuis","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.neubiorev.2016.01.001_bib0575","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1054\/ghir.1999.0096","article-title":"Insulin-like growth factor binding protein (IGFBP) proteolysis: occurrence, identification, role and regulation","volume":"9","author":"Maile","year":"1999","journal-title":"Growth Horm. IGF Res."},{"issue":"8","key":"10.1016\/j.neubiorev.2016.01.001_bib0580","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1210\/mend-5-8-1158","article-title":"Localization of type I insulin-like growth factor receptor messenger RNA in the adult rat brain by in situ hybridization","volume":"5","author":"Marks","year":"1991","journal-title":"Mol. Endocrinol."},{"issue":"1","key":"10.1016\/j.neubiorev.2016.01.001_bib0585","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1128\/MCB.17.1.248","article-title":"Specific activation of p85-p110 phosphatidylinositol 3'-kinase stimulates DNA synthesis by ras- and p70 S6 kinase-dependent pathways","volume":"17","author":"McIlroy","year":"1997","journal-title":"Mol. Cell. Biol."},{"issue":"6","key":"10.1016\/j.neubiorev.2016.01.001_bib0590","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1083\/jcb.121.6.1397","article-title":"A role for TGF-beta in oligodendrocyte differentiation","volume":"121","author":"McKinnon","year":"1993","journal-title":"J. Cell. Biol."},{"issue":"6","key":"10.1016\/j.neubiorev.2016.01.001_bib0595","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.tibs.2011.03.006","article-title":"The Ras-ERK and PI3K-mTOR pathways: cross-talk and compensation","volume":"36","author":"Mendoza","year":"2011","journal-title":"Trends Biochem. Sci."},{"issue":"4","key":"10.1016\/j.neubiorev.2016.01.001_bib0600","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.neuron.2010.09.024","article-title":"Single-synapse analysis of a diverse synapse population: proteomic imaging methods and markers","volume":"68","author":"Micheva","year":"2010","journal-title":"Neuron"},{"issue":"2","key":"10.1016\/j.neubiorev.2016.01.001_bib0605","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.neurobiolaging.2008.04.002","article-title":"Defects in IGF-1 receptor, insulin receptor and IRS-1\/2 in Alzheimer's disease indicate possible resistance to IGF-1 and insulin signalling","volume":"31","author":"Moloney","year":"2010","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neubiorev.2016.01.001_bib0610","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/j.1749-6632.1988.tb27124.x","article-title":"Insulin-like growth factor-I stimulates regeneration of oligodendrocytes in vitro","volume":"540","author":"Mozell","year":"1988","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"3","key":"10.1016\/j.neubiorev.2016.01.001_bib0615","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/BF03343833","article-title":"Relationships between cortisol, dehydroepiandrosterone sulphate and insulin-like growth factor-I system in dementia","volume":"24","author":"Murialdo","year":"2001","journal-title":"J. Endocrinol. Invest."},{"issue":"1","key":"10.1016\/j.neubiorev.2016.01.001_bib0620","doi-asserted-by":"crossref","first-page":"311","DOI":"10.3233\/JAD-2010-1221","article-title":"Alzheimer\u2019s disease and the amyloid-beta peptide","volume":"19","author":"Murphy","year":"2010","journal-title":"J. Alzheimers Dis."},{"issue":"6","key":"10.1016\/j.neubiorev.2016.01.001_bib0625","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1159\/000017188","article-title":"Decreased plasma insulin-like growth factor-I level in familial Alzheimer\u2019s disease patients carrying the Swedish APP 670\/671 mutation","volume":"10","author":"Mustafa","year":"1999","journal-title":"Dement. Geriatr. Cognit. Disord."},{"issue":"1\u20132","key":"10.1016\/j.neubiorev.2016.01.001_bib0630","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jns.2005.04.011","article-title":"Therapeutic benefit of intrathecal injection of insulin-like growth factor-1 in a mouse model of amyotrophic lateral sclerosis","volume":"235","author":"Nagano","year":"2005","journal-title":"J. Neurol. Sci."},{"issue":"7","key":"10.1016\/j.neubiorev.2016.01.001_bib0635","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1179\/016164105X39860","article-title":"Beneficial effects of intrathecal IGF-1 administration in patients with amyotrophic lateral sclerosis","volume":"27","author":"Nagano","year":"2005","journal-title":"Neurol. Res."},{"issue":"12","key":"10.1016\/j.neubiorev.2016.01.001_bib0640","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1002\/neu.480241203","article-title":"Insulin-like growth factors: putative muscle-derived trophic agents that promote motoneuron survival","volume":"24","author":"Neff","year":"1993","journal-title":"J. Neurobiol."},{"key":"10.1016\/j.neubiorev.2016.01.001_bib0645","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1002\/ana.1024","article-title":"Neuropeptides and neurotrophins in neonatal blood of children with autism ormental retardation","volume":"49","author":"Nelson","year":"2001","journal-title":"Ann. Neurol."},{"issue":"5","key":"10.1016\/j.neubiorev.2016.01.001_bib0650","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.neuron.2010.08.007","article-title":"Neuronal activity drives localized blood\u2013brain-barrier transport of serum insulin-like growth factor-I into the CNS","volume":"67","author":"Nishijima","year":"2010","journal-title":"Neuron"},{"issue":"3","key":"10.1016\/j.neubiorev.2016.01.001_bib0655","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1159\/000054584","article-title":"Interactions of IGF-1 with the blood\u2013brain barrier in vivo and in situ","volume":"72","author":"Pan","year":"2000","journal-title":"Neuroendocrinology"},{"issue":"12","key":"10.1016\/j.neubiorev.2016.01.001_bib0660","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1111\/j.1532-5415.1995.tb06613.x","article-title":"Insulin-like growth factor 1 and functional status in healthy older men","volume":"43","author":"Papadakis","year":"1995","journal-title":"J. Am. Geriatr. Soc."},{"issue":"7","key":"10.1016\/j.neubiorev.2016.01.001_bib0665","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1097\/00004647-199707000-00001","article-title":"Drug delivery to the brain","volume":"17","author":"Pardridge","year":"1997","journal-title":"J. Cereb. Blood Flow Metab."},{"issue":"9","key":"10.1016\/j.neubiorev.2016.01.001_bib0670","doi-asserted-by":"crossref","first-page":"3413","DOI":"10.1523\/JNEUROSCI.2921-13.2014","article-title":"Postsynaptic FMRP promotes the pruning of cell-to-cell connections among pyramidal neurons in the L5A neocortical network","volume":"34","author":"Patel","year":"2014","journal-title":"J. Neurosci."},{"issue":"8","key":"10.1016\/j.neubiorev.2016.01.001_bib0675","doi-asserted-by":"crossref","first-page":"3112","DOI":"10.1128\/MCB.24.8.3112-3124.2004","article-title":"S6K1(\u2212\/\u2212)\/S6K2(\u2212\/\u2212) mice exhibit perinatal lethality and rapamycin-sensitive 5\u2032-terminal oligopyrimidine mRNA translation and reveal a mitogen-activated protein kinase-dependent S6 kinase pathway","volume":"24","author":"Pende","year":"2004","journal-title":"Mol. Cell. Biol."},{"issue":"6","key":"10.1016\/j.neubiorev.2016.01.001_bib0680","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1210\/endo.135.6.7988416","article-title":"Developmentally regulated expression of the preproinsulin gene in the chicken embryo during gastrulation and neurulation","volume":"135","author":"Perez-Villamil","year":"1994","journal-title":"Endocrinology"},{"issue":"Pt. 4","key":"10.1016\/j.neubiorev.2016.01.001_bib0685","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1113\/jphysiol.2008.160929","article-title":"Synaptic ionotropic glutamate receptors and plasticity are developmentally altered in the CA1 field of Fmr1 knockout mice","volume":"587","author":"Pilpel","year":"2009","journal-title":"J. Physiol."},{"issue":"8","key":"10.1016\/j.neubiorev.2016.01.001_bib0690","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1111\/j.0953-816X.2004.03320.x","article-title":"In vivo effects of insulin-like growth factor-I (IGF-I) on prenatal and early postnatal development of the central nervous system","volume":"19","author":"Popken","year":"2004","journal-title":"Eur. J. Neurosci."},{"issue":"4","key":"10.1016\/j.neubiorev.2016.01.001_bib0695","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1210\/endo.132.4.8462444","article-title":"Insulin and insulin-like growth factor I receptors: are there functional distinctions?","volume":"132","author":"Prager","year":"1993","journal-title":"Endocrinology"},{"key":"10.1016\/j.neubiorev.2016.01.001_bib0700","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1146\/annurev.ph.47.030185.002233","article-title":"The nature and regulation of the receptors for insulin-like growth factors","volume":"47","author":"Rechler","year":"1985","journal-title":"Annu. Rev. Physiol."},{"issue":"5","key":"10.1016\/j.neubiorev.2016.01.001_bib0705","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1210\/endo.135.5.7525251","article-title":"Insulin-like growth factors cross the blood\u2013brain barrier","volume":"135","author":"Reinhardt","year":"1994","journal-title":"Endocrinology"},{"key":"10.1016\/j.neubiorev.2016.01.001_bib0710","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1159\/000095957","article-title":"Insulin-like growth factor delivery across the blood\u2013brain barrier. Potential use of IGF-1 as a drug in child neurology","volume":"6","author":"Riikonen","year":"2006","journal-title":"Chemotherapy"},{"issue":"8","key":"10.1016\/j.neubiorev.2016.01.001_bib0715","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1016\/S0021-9258(17)40889-1","article-title":"The amino acid sequence of human insulin-like growth factor I and its structural homology with proinsulin","volume":"253","author":"Rinderknecht","year":"1978","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.neubiorev.2016.01.001_bib0720","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1159\/000115751","article-title":"The Mayo Clinic Study of Aging: design and sampling, participation, baseline measures and sample characteristics","volume":"30","author":"Roberts","year":"2008","journal-title":"Neuroepidemiology"},{"issue":"2","key":"10.1016\/j.neubiorev.2016.01.001_bib0725","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s100720170011","article-title":"The prevalence of multiple sclerosis in the world: an update","volume":"22","author":"Rosati","year":"2001","journal-title":"Neurol. Sci."},{"issue":"4","key":"10.1016\/j.neubiorev.2016.01.001_bib0730","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1097\/MOP.0b013e3282094126","article-title":"The role of recombinant insulin-like growth factor I in the treatment of the short child","volume":"19","author":"Rosenbloom","year":"2007","journal-title":"Curr. Opin. Pediatr."},{"issue":"14","key":"10.1016\/j.neubiorev.2016.01.001_bib0735","doi-asserted-by":"crossref","first-page":"3560","DOI":"10.1523\/JNEUROSCI.4354-04.2005","article-title":"Shank expression is sufficient to induce functional dendritic spine synapses in aspiny neurons","volume":"25","author":"Roussignol","year":"2005","journal-title":"J. Neurosci."},{"issue":"86","key":"10.1016\/j.neubiorev.2016.01.001_bib0740","doi-asserted-by":"crossref","first-page":"86ra49","DOI":"10.1126\/scitranslmed.3002166","article-title":"Protein interactome reveals converging molecular pathways among autism disorders","volume":"3","author":"Sakai","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.neubiorev.2016.01.001_bib0745","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1749-6632.1993.tb26216.x","article-title":"The biological role of truncated insulin-like growth factor-1 and the tripeptide GPE in the central nervous system","volume":"692","author":"Sara","year":"1993","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.neubiorev.2016.01.001_bib0750","first-page":"199","article-title":"The somatomedins throughout development","author":"Sara","year":"1981","journal-title":"Bull Schweiz. Akad. Med. Wiss."},{"issue":"2","key":"10.1016\/j.neubiorev.2016.01.001_bib0755","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0166-2236(99)01499-X","article-title":"Dendritic spine formation and pruning: common cellular mechanisms?","volume":"23","author":"Segal","year":"2000","journal-title":"Trends Neurosci."},{"issue":"1","key":"10.1016\/j.neubiorev.2016.01.001_bib0760","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/0006-8993(90)91055-L","article-title":"Dose-dependent destruction of the coeruleus-cortical and nigral-striatal projections by MPTP","volume":"527","author":"Seniuk","year":"1990","journal-title":"Brain Res."},{"issue":"21","key":"10.1016\/j.neubiorev.2016.01.001_bib0765","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1212\/01.wnl.0000335163.88054.e7","article-title":"Growth hormone secretagogue MK-677: no clinical effect on AD progression in a randomized trial","volume":"71","author":"Sevigny","year":"2008","journal-title":"Neurology"},{"issue":"7475","key":"10.1016\/j.neubiorev.2016.01.001_bib0770","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/nature12618","article-title":"SHANK3 and IGF1 restore synaptic deficits in neurons from 22q13 deletion syndrome patients","volume":"503","author":"Shcheglovitov","year":"2013","journal-title":"Nature"},{"issue":"Pt. 11","key":"10.1016\/j.neubiorev.2016.01.001_bib0775","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1242\/jcs.113.11.1851","article-title":"The Shank family of scaffold proteins","volume":"113","author":"Sheng","year":"2000","journal-title":"J. Cell Sci."},{"issue":"1","key":"10.1016\/j.neubiorev.2016.01.001_bib0780","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/2040-2392-4-18","article-title":"Prospective investigation of autism and genotype-phenotype correlations in 22q13 deletion syndrome and SHANK3 deficiency, Mol","volume":"4","author":"Soorya","year":"2013","journal-title":"Autism"},{"issue":"22","key":"10.1016\/j.neubiorev.2016.01.001_bib0785","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1212\/01.wnl.0000335970.78664.36","article-title":"Subcutaneous IGF-1 is not beneficial in 2-year ALS trial","volume":"71","author":"Sorenson","year":"2008","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.neubiorev.2016.01.001_bib0790","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S1097-2765(04)00211-4","article-title":"The IGF-1\/PI3K\/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors","volume":"14","author":"Stitt","year":"2004","journal-title":"Mol. Cell"},{"issue":"4","key":"10.1016\/j.neubiorev.2016.01.001_bib0795","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/S0306-4522(96)00545-3","article-title":"In situ detection of apoptotic nuclei in the substantia nigra compacta of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice using terminal deoxynucleotidyl transferase labelling and acridine orange staining","volume":"77","author":"Tatton","year":"1997","journal-title":"Neuroscience"},{"issue":"2","key":"10.1016\/j.neubiorev.2016.01.001_bib0800","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.neuroscience.2004.05.029","article-title":"Delivery of insulin-like growth factor-I to the rat brain and spinal cord along olfactory and trigeminal pathways following intranasal administration","volume":"127","author":"Thorne","year":"2004","journal-title":"Neuroscience"},{"issue":"1","key":"10.1016\/j.neubiorev.2016.01.001_bib0805","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1677\/joe.0.1280097","article-title":"Effects of full-length and truncated insulin-like growth factor-I on nitrogen balance and muscle protein metabolism in nitrogen-restricted rats","volume":"128","author":"Tomas","year":"1991","journal-title":"J. Endocrinol."},{"issue":"3","key":"10.1016\/j.neubiorev.2016.01.001_bib0810","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/0306-4522(90)90332-X","article-title":"Trophic effects of insulin-like growth factor-I on fetal rat hypothalamic cells in culture","volume":"35","author":"Torres-Aleman","year":"1990","journal-title":"Neuroscience"},{"issue":"2","key":"10.1016\/j.neubiorev.2016.01.001_bib0815","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0306-4522(97)00367-9","article-title":"Insulin-like growth factor-I modulation of cerebellar cell populations is developmentally stage-dependent and mediated by specific intracellular pathways","volume":"83","author":"Torres-Aleman","year":"1998","journal-title":"Neuroscience"},{"issue":"6","key":"10.1016\/j.neubiorev.2016.01.001_bib0820","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1073\/pnas.0812394106","article-title":"Partial reversal of Rett syndrome-like symptoms in MeCP2 mutant mice","volume":"106","author":"Tropea","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"11","key":"10.1016\/j.neubiorev.2016.01.001_bib0825","doi-asserted-by":"crossref","first-page":"6074","DOI":"10.1074\/jbc.273.11.6074","article-title":"Insulin-like growth factor (IGF)-binding protein 5 forms an alternative ternary complex with IGFs and the acid-labile subunit","volume":"273","author":"Twigg","year":"1998","journal-title":"J. Biol. Chem."},{"issue":"9","key":"10.1016\/j.neubiorev.2016.01.001_bib0830","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1017\/S0012162201001116","article-title":"Low levels of insulin-like growth factor-I in cerebrospinal fluid in children with autism","volume":"43","author":"Vanhala","year":"2001","journal-title":"Dev. Med. Child Neurol."},{"issue":"8","key":"10.1016\/j.neubiorev.2016.01.001_bib0835","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/nrn1722","article-title":"Astrocytes, from brain glue to communication elements: the revolution continues","volume":"6","author":"Volterra","year":"2005","journal-title":"Nat. Rev. Neurosci."},{"issue":"2","key":"10.1016\/j.neubiorev.2016.01.001_bib0840","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/jnc.12505","article-title":"Identification of two novel Shank3 transcripts in the developing mouse neocortex","volume":"128","author":"Waga","year":"2014","journal-title":"J. Neurochem."},{"issue":"2\u20134","key":"10.1016\/j.neubiorev.2016.01.001_bib0845","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/0955-2235(95)00007-0","article-title":"In vivo actions of IGF analogues with poor affinities for IGFBPs: metabolic and growth effects in pigs of different ages and GH responsiveness","volume":"6","author":"Walton","year":"1995","journal-title":"Prog. Growth Factor Res."},{"issue":"12","key":"10.1016\/j.neubiorev.2016.01.001_bib0850","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1007\/s10495-010-0547-z","article-title":"Insulin-like growth factor 1 protects human neuroblastoma cells SH-EP1 against MPP+-induced apoptosis by AKT\/GSK-3beta\/JNK signaling","volume":"15","author":"Wang","year":"2010","journal-title":"Apoptosis"},{"issue":"10","key":"10.1016\/j.neubiorev.2016.01.001_bib0855","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1111\/j.1532-5415.2005.53524.x","article-title":"Relationship between serum insulin-like growth factor-1 levels and Alzheimer\u2019s disease and vascular dementia","volume":"53","author":"Watanabe","year":"2005","journal-title":"J. Am. Geriatr. Soc."},{"issue":"1\u20132","key":"10.1016\/j.neubiorev.2016.01.001_bib0860","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0005-2760(98)00139-8","article-title":"Structure and function of phosphoinositide 3-kinases","volume":"1436","author":"Wymann","year":"1998","journal-title":"Biochim. Biophys. Acta"},{"issue":"4","key":"10.1016\/j.neubiorev.2016.01.001_bib0865","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.7314\/APJCP.2012.13.4.1183","article-title":"Effect of insulin-like growth factor-1 on bone morphogenetic protein-2 expression in hepatic carcinoma SMMC7721 cells through the p38 MAPK signaling pathway","volume":"13","author":"Xu","year":"2012","journal-title":"Asian Pac. J. Cancer Prev."},{"issue":"13","key":"10.1016\/j.neubiorev.2016.01.001_bib0870","doi-asserted-by":"crossref","first-page":"7324","DOI":"10.1073\/pnas.96.13.7324","article-title":"Normal growth and development in the absence of hepatic insulin-like growth factor I","volume":"96","author":"Yakar","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"6","key":"10.1016\/j.neubiorev.2016.01.001_bib0875","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1210\/endo.135.6.7988428","article-title":"Generation of des-(1\u20133) insulin-like growth factor-I in serum by an acid protease","volume":"135","author":"Yamamoto","year":"1994","journal-title":"Endocrinology"},{"issue":"7","key":"10.1016\/j.neubiorev.2016.01.001_bib0880","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.neuropharm.2005.06.004","article-title":"Suppression of two major Fragile X Syndrome mouse model phenotypes by the mGluR5 antagonist MPEP","volume":"49","author":"Yan","year":"2005","journal-title":"Neuropharmacology"},{"issue":"11","key":"10.1016\/j.neubiorev.2016.01.001_bib0885","doi-asserted-by":"crossref","first-page":"7344","DOI":"10.1523\/JNEUROSCI.15-11-07344.1995","article-title":"In vivo actions of insulin-like growth factor-I (IGF-I) on brain myelination: studies of IGF-I and IGF binding protein-1 (IGFBP-1) transgenic mice","volume":"15","author":"Ye","year":"1995","journal-title":"J. Neurosci."},{"issue":"14","key":"10.1016\/j.neubiorev.2016.01.001_bib0890","doi-asserted-by":"crossref","first-page":"6041","DOI":"10.1523\/JNEUROSCI.22-14-06041.2002","article-title":"Myelination is altered in insulin-like growth factor-I null mutant mice","volume":"22","author":"Ye","year":"2002","journal-title":"J. Neurosci."},{"issue":"4","key":"10.1016\/j.neubiorev.2016.01.001_bib0895","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1002\/jnr.20288","article-title":"Astrocyte-specific overexpression of insulin-like growth factor-I promotes brain overgrowth and glial fibrillary acidic protein expression","volume":"78","author":"Ye","year":"2004","journal-title":"J. Neurosci. Res."},{"issue":"4","key":"10.1016\/j.neubiorev.2016.01.001_bib0900","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1002\/glia.20469","article-title":"Insulin-like growth factor type 1 receptor signaling in the cells of oligodendrocyte lineage is required for normal in vivo oligodendrocyte development and myelination","volume":"55","author":"Zeger","year":"2007","journal-title":"Glia"}],"container-title":["Neuroscience & Biobehavioral Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149763415300452?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149763415300452?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T16:16:55Z","timestamp":1654100215000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149763415300452"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":180,"alternative-id":["S0149763415300452"],"URL":"https:\/\/doi.org\/10.1016\/j.neubiorev.2016.01.001","relation":{},"ISSN":["0149-7634"],"issn-type":[{"value":"0149-7634","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The therapeutic potential of insulin-like growth factor-1 in central nervous system disorders","name":"articletitle","label":"Article Title"},{"value":"Neuroscience & Biobehavioral Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neubiorev.2016.01.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}